Charles Robb

Charles Robb

Chief Business Officer and SecretaryatCorcept Therapeutics· In proxies 2021–2025

Pay in FY2025+54% from the year before · Corcept Therapeutics stock -30.9% the same year

Charles Robb was paid $6.4M in FY2025 (Dec), up 54%. Corcept Therapeutics stock fell 30.9% that year.

Pay$100 in the stock at the end of FY20 → $133
Pay is from the Summary Compensation Table of each Corcept Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Corcept TherapeuticsPublic company · 5 yr
    • Chief Business Officer and Secretary2021 – Present · 5 yrStock in role +217%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?